PRESS RELEASE published on 07/30/2026 at 22:15, 1 month 30 days ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL Communiqué mensuel sur les droits de vote et d'actions de Nanobiotix, société de biotechnologie, cotée sur Euronext Paris et Nasdaq, avec plus de 30 familles de brevets en nanotechnologie Euronext Paris Droits De Vote Biotechnologie Brevets NANOBIOTIX
PRESS RELEASE published on 07/30/2026 at 22:15, 1 month 30 days ago Voting Rights and Shares Capital of the Company Nanobiotix announces voting rights and shares capital update. Company listed on Euronext Paris and Nasdaq. Pioneering biotech firm with disruptive therapeutic approaches Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 06/05/2026 at 22:20, 3 months 24 days ago Monthly publication of Nanobiotix voting rights Euronext Paris Voting Rights Actions Nasdaq NANOBIOTIX
BRIEF published on 06/05/2026 at 22:20, 3 months 24 days ago Publication mensuelle des droits de vote de Nanobiotix Euronext Paris Droits De Vote Actions Nasdaq NANOBIOTIX
PRESS RELEASE published on 06/05/2026 at 22:15, 3 months 24 days ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Communiqué de presse concernant le nombre total de droits de vote et d'actions composant le capital social de Nanobiotix. Information mensuelle conforme aux réglementations financières Droits De Vote Euronext Capital Social Biotechnologie NANOBIOTIX
BRIEF published on 06/02/2026 at 22:35, 3 months 27 days ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
BRIEF published on 06/02/2026 at 22:35, 3 months 27 days ago Nanobiotix annonce ses progrès opérationnels et financiers pour le premier trimestre 2026. Mise À Jour Financière NANOBIOTIX JNJ-1900 AACR 2026 CBNPC
BRIEF published on 06/02/2026 at 22:35, 3 months 27 days ago Nanobiotix : Bilan du premier trimestre 2026 Biotechnologie Augmentation De Capital Essais Cliniques Nanotechnologie NBTXR3
BRIEF published on 06/02/2026 at 22:35, 3 months 27 days ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
PRESS RELEASE published on 06/02/2026 at 22:30, 3 months 27 days ago Nanobiotix Provides First Quarter 2026 Operational and Financial Update Nanobiotix provides operational and financial update for Q1 2026, including successful fundraising and clinical study advancements in cancer treatment Cancer Treatment Clinical Study Financial Update NANOBIOTIX Q1 2026
Published on 09/30/2026 at 11:00, 44 minutes ago High Tide Resources Stakes More Ground at Labrador West Iron Project as Drilling Concludes for 2026
Published on 09/30/2026 at 08:00, 3 hours 44 minutes ago Alpha Growth Management Opens Rep Office in Japan
Published on 09/30/2026 at 02:05, 9 hours 39 minutes ago Annual Report for the Year Ended 30 June 2026
Published on 09/30/2026 at 01:45, 9 hours 59 minutes ago Tungsten Eagle Development Corp. (Formerly Patriot Resources Corp.) Completes Fundamental Change, Closes $5,000,000 Concurrent Financing and to Commence Trading on the Canadian Securities Exchange
Published on 09/30/2026 at 00:55, 10 hours 49 minutes ago Core Silver Announces Private Placement of up to $1,000,000
Published on 09/30/2026 at 11:32, 12 minutes ago EQS-Adhoc: PALFINGER AG: Write-down of the Russian business and preparation for deconsolidation
Published on 09/30/2026 at 11:30, 14 minutes ago Form 8.3 - Zürcher Kantonalbank: Irish Residential Properties REIT plc
Published on 09/30/2026 at 11:25, 19 minutes ago HMS Bergbau AG: Final figures for the first half of 2026 published
Published on 09/30/2026 at 11:10, 33 minutes ago EQS-Adhoc: SBF adjusts its 2026 earnings forecast following the provisional insolvency administration of a customer
Published on 09/30/2026 at 11:05, 38 minutes ago Newronika Announces First Participant Implanted in ADVENT Pivotal Study
Published on 09/30/2026 at 08:45, 2 hours 59 minutes ago Air Liquide invests over 170 million euros to support a semiconductor leader expanding manufacturing capabilities in Japan
Published on 09/30/2026 at 08:45, 2 hours 59 minutes ago Air Liquide investit plus de 170 millions d’euros pour accompagner un leader des semi-conducteurs dans le développement de ses capacités de production au Japon
Published on 09/30/2026 at 08:31, 3 hours 12 minutes ago OPmobility signs an agreement to acquire Hyundai Mobis' lighting activity
Published on 09/30/2026 at 08:31, 3 hours 12 minutes ago OPmobility signe un accord pour acquérir l'activité éclairage de Hyundai Mobis